
D Margaret M Seaman
Examiner (ID: 4490, Phone: (571)272-0694 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1612, 1621, 1203, 1625 |
| Total Applications | 3087 |
| Issued Applications | 2266 |
| Pending Applications | 287 |
| Abandoned Applications | 567 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19578271
[patent_doc_number] => 12144350
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-19
[patent_title] => Heterocyclic compound and harmful arthropod control composition containing same
[patent_app_type] => utility
[patent_app_number] => 17/426938
[patent_app_country] => US
[patent_app_date] => 2020-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59707
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 2176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17426938
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/426938 | Heterocyclic compound and harmful arthropod control composition containing same | Jan 29, 2020 | Issued |
Array
(
[id] => 20302383
[patent_doc_number] => 12448361
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-21
[patent_title] => Method for purification of a bisphenol a dianhydride composition, bisphenol a dianhydride composition, poly(etherimide) derived from the bisphenol a dianhydride composition, and articles prepared therefrom
[patent_app_type] => utility
[patent_app_number] => 17/418446
[patent_app_country] => US
[patent_app_date] => 2020-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15497
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17418446
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/418446 | Method for purification of a bisphenol a dianhydride composition, bisphenol a dianhydride composition, poly(etherimide) derived from the bisphenol a dianhydride composition, and articles prepared therefrom | Jan 29, 2020 | Issued |
Array
(
[id] => 17460178
[patent_doc_number] => 20220073483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => METHOD OF MAKING A BIPHENOL DIANHYDRIDE COMPOSITION, METHOD FOR PURIFICATION OF A BIPHENOL DIANHYDRIDE, AND POLY(ETHERIMIDE)S DERIVED FROM THE BIPHENOL DIANHYDRIDE
[patent_app_type] => utility
[patent_app_number] => 17/417241
[patent_app_country] => US
[patent_app_date] => 2020-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16510
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17417241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/417241 | Method of making a biphenol dianhydride composition, method for purification of a biphenol dianhydride, and poly(etherimide)s derived from the biphenol dianhydride | Jan 28, 2020 | Issued |
Array
(
[id] => 15962997
[patent_doc_number] => 20200165250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => Small Molecule Inhibitors of the JAK Family of Kinases
[patent_app_type] => utility
[patent_app_number] => 16/776243
[patent_app_country] => US
[patent_app_date] => 2020-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16776243
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/776243 | Small molecule inhibitors of the JAK family of kinases | Jan 28, 2020 | Issued |
Array
(
[id] => 17074845
[patent_doc_number] => 11111229
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-07
[patent_title] => Tetrahydroquinoline compositions as BET bromodomain inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/774515
[patent_app_country] => US
[patent_app_date] => 2020-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73656
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16774515
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/774515 | Tetrahydroquinoline compositions as BET bromodomain inhibitors | Jan 27, 2020 | Issued |
Array
(
[id] => 17821441
[patent_doc_number] => 11426364
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Immunomodulator compounds
[patent_app_type] => utility
[patent_app_number] => 16/751019
[patent_app_country] => US
[patent_app_date] => 2020-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32021
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16751019
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/751019 | Immunomodulator compounds | Jan 22, 2020 | Issued |
Array
(
[id] => 16482362
[patent_doc_number] => 20200375962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => INDANE-AMINES AS PD-L1 ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/742104
[patent_app_country] => US
[patent_app_date] => 2020-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16742104
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/742104 | Indane-amines as PD-L1 antagonists | Jan 13, 2020 | Issued |
Array
(
[id] => 15898251
[patent_doc_number] => 20200148644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM
[patent_app_type] => utility
[patent_app_number] => 16/740516
[patent_app_country] => US
[patent_app_date] => 2020-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 506
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16740516
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/740516 | CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM | Jan 12, 2020 | Abandoned |
Array
(
[id] => 15831779
[patent_doc_number] => 20200131171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/730058
[patent_app_country] => US
[patent_app_date] => 2019-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16730058
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/730058 | Dual mechanism inhibitors for the treatment of disease | Dec 29, 2019 | Issued |
Array
(
[id] => 19897805
[patent_doc_number] => 12275709
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-15
[patent_title] => Process for the preparation of exo-tert-butyl N-(3-azabicyclo[3.2.1]octan-8-yl)carbamate
[patent_app_type] => utility
[patent_app_number] => 17/418480
[patent_app_country] => US
[patent_app_date] => 2019-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17418480
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/418480 | Process for the preparation of exo-tert-butyl N-(3-azabicyclo[3.2.1]octan-8-yl)carbamate | Dec 23, 2019 | Issued |
Array
(
[id] => 16421851
[patent_doc_number] => 20200347049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => 6-5 FUSED RINGS AS C5a INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/723433
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16723433
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/723433 | 6-5 fused rings as C5a inhibitors | Dec 19, 2019 | Issued |
Array
(
[id] => 17428284
[patent_doc_number] => 20220055992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => Process for preparing 2-alkoxy-4-amino-5-methyl-pyridines and/or 2-alkoxy-4-alkylamino-5-methyl-pyridines
[patent_app_type] => utility
[patent_app_number] => 17/415783
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5026
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17415783
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/415783 | Process for preparing 2-alkoxy-4-amino-5-methyl-pyridines and/or 2-alkoxy-4-alkylamino-5-methyl-pyridines | Dec 19, 2019 | Issued |
Array
(
[id] => 17563094
[patent_doc_number] => 20220127243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => COMPOUND FOR USE IN RETINAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/309611
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309611
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/309611 | Compound for use in retinal diseases | Dec 17, 2019 | Issued |
Array
(
[id] => 17443661
[patent_doc_number] => 20220064166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 17/415400
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21889
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17415400
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/415400 | Substituted heterocycle fused gamma-carbolines synthesis | Dec 16, 2019 | Issued |
Array
(
[id] => 17134767
[patent_doc_number] => 11136313
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Compounds, compositions, and methods for modulating CFTR
[patent_app_type] => utility
[patent_app_number] => 16/716765
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60617
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16716765
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/716765 | Compounds, compositions, and methods for modulating CFTR | Dec 16, 2019 | Issued |
Array
(
[id] => 16533256
[patent_doc_number] => 10875839
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-29
[patent_title] => Somatostatin modulators and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/712620
[patent_app_country] => US
[patent_app_date] => 2019-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48594
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16712620
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/712620 | Somatostatin modulators and uses thereof | Dec 11, 2019 | Issued |
Array
(
[id] => 16564209
[patent_doc_number] => 10889567
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-12
[patent_title] => Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/712951
[patent_app_country] => US
[patent_app_date] => 2019-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28061
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16712951
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/712951 | Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Dec 11, 2019 | Issued |
Array
(
[id] => 17414007
[patent_doc_number] => 20220048911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => CO-CRYSTALS, METHOD AND APPARATUS FOR FORMING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/312966
[patent_app_country] => US
[patent_app_date] => 2019-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312966
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/312966 | Co-crystals, method and apparatus for forming the same | Dec 10, 2019 | Issued |
Array
(
[id] => 18195883
[patent_doc_number] => 20230049402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => NOVEL PHENOL COMPOUND OR SALT THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/780591
[patent_app_country] => US
[patent_app_date] => 2019-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55024
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17780591
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/780591 | Phenol compound or salt thereof | Dec 5, 2019 | Issued |
Array
(
[id] => 17512546
[patent_doc_number] => 11291662
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-05
[patent_title] => Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
[patent_app_type] => utility
[patent_app_number] => 16/704713
[patent_app_country] => US
[patent_app_date] => 2019-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 18917
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16704713
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/704713 | Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide | Dec 4, 2019 | Issued |